Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Ospedale Regionale di Bellinzona e Valli, Bellinzona

Kantonsspital St. Gallen, Sankt Gallen

Weill Cornell Medical College, New York

Johns Hopkins Hospital/Health System, Baltimore

Fundacion Jimenez Diaz (Clinica de la Concepcion), Madrid

Hospital Madrid Norte Sanchinarro, Madrid

Ohio State University, Columbus

Universitätsklinikum Heidelberg, Heidelberg

Eberhard-Karls-Universität Tübingen, Tübingen

Stanford University, Palo Alto

Yale Cancer Center, New Haven

Dana-Farber Cancer Institute, Boston

Levine Cancer Institute, Charlotte

University of Texas MD Anderson Cancer Center, Houston

Royal Marsden NHS Trust (Surrey), Sutton

Freeman Hospital, Newcastle